The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 201–300 of 1,072
Li, R., Li, R., Li, X., Fu, D., Zhu, B., Tian, H., Luo, Y., & Zhu, H. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12781 · Cited by 287
“, 2015a; Petolino, 2015), but the use of these tools is both laborious and time-consuming (Doudna and Charpentier, 2014).”
MethodFrizzled proteins are colonic epithelial receptors for C. difficile toxin B
Tao, L., Zhang, J., Meraner, P., Tovaglieri, A., Wu, X., Gerhard, R., Zhang, X., Stallcup, W. B., Miao, J., He, X., et al. (2016) · Nature · doi:10.1038/nature19799 · Cited by 279
Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease
Qin, W., Dion, S. L., Kutny, P. M., Zhang, Y., Cheng, A. W., Jillette, N. L., Malhotra, A., Geurts, A. M., Chen, Y.-G., & Wang, H. (2015) · Genetics · doi:10.1534/genetics.115.176594 · Cited by 293
“…re-peat (CRISPR) locus and the CRISPR-associated protein (Cas) system, CRISPR/Cas9, is an acquired immune system in bacteria and archaea that has recently been exploited for genome engineering of many species and cell types (Jinek et al. 2012; Doudna and Charpentier 2014; Hsu et al. 2014).”
BackgroundZmCCT9 enhances maize adaptation to higher latitudes
Huang, C., Sun, H., Xu, D., Chen, Q., Liang, Y., Wang, X., Xu, G., Tian, J., Wang, C., Li, D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718058115 · Cited by 292
“To validate the function of ZmCCT9, we knocked out the endogenous ZmCCT9 gene in maize inbred line ZC01 using CRISPR/ Cas9 technology (31, 32).”
MethodTranslational value of mouse models in oncology drug development
Gould, S. E., Junttila, M. R., & de Sauvage, F. J. (2015) · Nature Medicine · doi:10.1038/nm.3853 · Cited by 293
A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
Dagdas, Y. S., Chen, J. S., Sternberg, S. H., Doudna, J. A., & Yildiz, A. (2017) · Science Advances · doi:10.1126/sciadv.aao0027 · Cited by 293
“By manipulating the sequence of the single-guide RNA (sgRNA), Cas9-sgRNA can be programmed to target any DNA sequence flanked by a PAM (6, 8-10), making it a powerful genome editing tool.”
BackgroundInfluentialSelf-citationPAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures
Gleditzsch, D., Pausch, P., Müller-Esparza, H., Özcan, A., Guo, X., Bange, G., & Randau, L. (2019) · RNA Biology · doi:10.1080/15476286.2018.1504546 · Cited by 280
Recent Advances in CRISPR/Cas9 Delivery Strategies
Yip, B. (2020) · Biomolecules · doi:10.3390/biom10060839 · Cited by 292
Gene discovery in amyotrophic lateral sclerosis: implications for clinical management
Al-Chalabi, A., van den Berg, L. H., & Veldink, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.182 · Cited by 287
Rational design of a split-Cas9 enzyme complex
Wright, A. V., Sternberg, S. H., Taylor, D. W., Staahl, B. T., Bardales, J. A., Kornfeld, J. E., & Doudna, J. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501698112 · Cited by 286
Self-citationPROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Braatz, J., Harloff, H.-J., Mascher, M., Stein, N., Himmelbach, A., & Jung, C. (2017) · Plant Physiology · doi:10.1104/pp.17.00426 · Cited by 265
“The Cas9 nuclease can easily be programmed to induce double-strand breaks within a target sequence (Doudna and Charpentier, 2014).”
BackgroundA new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Huang, W., Chen, T.-Q., Fang, K., Zeng, Z.-C., Ye, H., & Chen, Y.-Q. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01129-8 · Cited by 275
ARMMs as a versatile platform for intracellular delivery of macromolecules
Wang, Q., Yu, J., Kadungure, T., Beyene, J., Zhang, H., & Lu, Q. (2018) · Nature Communications · doi:10.1038/s41467-018-03390-x · Cited by 262
Belmonte, J. C. I., Callaway, E. M., Caddick, S. J., Churchland, P., Feng, G., Homanics, G. E., Lee, K.-F., Leopold, D. A., Miller, C. T., Mitchell, J. F., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.021 · Cited by 273
“In recent years, gene editing has become much more precise through use of programmable nucleases (Doudna and Charpentier, 2014).”
Lancet Commission: Stem cells and regenerative medicine
Cossu, G., Birchall, M., Brown, T., De Coppi, P., Culme-Seymour, E., Gibbon, S., Hitchcock, J., Mason, C., Montgomery, J., Morris, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31366-1 · Cited by 272
Elucidating the Role of Effectors in Plant-Fungal Interactions: Progress and Challenges
Selin, C., de Kievit, T. R., Belmonte, M. F., & Fernando, W. G. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00600 · Cited by 263
“The DSB within the DNA initiates the repair mechanism (non-homologous end joining pathway) resulting in short deletions or substitutions, which may cause frameshifts or generate premature stop codons within the ORF of the target DNA (Doudna and Charpentier, 2014).”
BackgroundInfluentialFrom the RNA world to the clinic
Sullenger, B. A., & Nair, S. (2016) · Science · doi:10.1126/science.aad8709 · Cited by 274
Hoshijima, K., Jurynec, M. J., Klatt Shaw, D., Jacobi, A. M., Behlke, M. A., & Grunwald, D. J. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.10.004 · Cited by 260
Canny, M. D., Moatti, N., Wan, L. C. K., Fradet-Turcotte, A., Krasner, D., Mateos-Gomez, P. A., Zimmermann, M., Orthwein, A., Juang, Y.-C., Zhang, W., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4021 · Cited by 271
CRISPR-Cas9 for cancer therapy: Opportunities and challenges
Chen, M., Mao, A., Xu, M., Weng, Q., Mao, J., & Ji, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.017 · Cited by 272
Jiang, W., Zhao, X., Gabrieli, T., Lou, C., Ebenstein, Y., & Zhu, T. F. (2015) · Nature Communications · doi:10.1038/ncomms9101 · Cited by 267
AIRE expands: new roles in immune tolerance and beyond
Anderson, M. S., & Su, M. A. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.9 · Cited by 262
CRISPR/Cas9-mediated genome editing of the fatty acid desaturase 2 gene in Brassica napus
Okuzaki, A., Ogawa, T., Koizuka, C., Kaneko, K., Inaba, M., Imamura, J., & Koizuka, N. (2018) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2018.04.025 · Cited by 256
Khan, A., Pan, X., Najeeb, U., Tan, D. K. Y., Fahad, S., Zahoor, R., & Luo, H. (2018) · Biological Research · doi:10.1186/s40659-018-0198-z · Cited by 261
Shepard, L. A., Penuel, W. R., & Pellegrino, J. W. (2018) · Educational Measurement: Issues and Practice · doi:10.1111/emip.12189 · Cited by 217
“Then they apply these understandings to build an even more sophisticated understanding of genetics through the study of powerful emerging gene editing technology, CRISPR-Cas9 (Doudna & Charpentier, 2014).”
BackgroundVennin, C., Mélénec, P., Rouet, R., Nobis, M., Cazet, A. S., Murphy, K. J., Herrmann, D., Reed, D. A., Lucas, M. C., Warren, S. C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10968-6 · Cited by 268
The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops
Khatodia, S., Bhatotia, K., Passricha, N., Khurana, S. M. P., & Tuteja, N. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00506 · Cited by 267
“The NUC domain further accommodates two nuclease sites, RuvC and HNH, and also a PAM-interacting site (Doudna and Charpentier, 2014; Jinek et al., 2014).”
BackgroundMethodHighly efficient CRISPR mutagenesis by microhomology-mediated end joining in Aspergillus fumigatus
Zhang, C., Meng, X., Wei, X., & Lu, L. (2016) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.12.007 · Cited by 264
RNA Interference Mechanisms and Applications in Plant Pathology
Rosa, C., Kuo, Y.-W., Wuriyanghan, H., & Falk, B. W. (2018) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080417-050044 · Cited by 264
Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9
Singh, D., Sternberg, S. H., Fei, J., Doudna, J. A., & Ha, T. (2016) · Nature Communications · doi:10.1038/ncomms12778 · Cited by 263
Self-citationTargeted genome-modification tools and their advanced applications in crop breeding
Li, B., Sun, C., Li, J., & Gao, C. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00720-2 · Cited by 233
Konstantakos, V., Nentidis, A., Krithara, A., & Paliouras, G. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac192 · Cited by 241
“Due to its simplicity, it has been rapidly and widely adopted by the scientific community to target and modify the genomes of a vast array of cells and organisms (3).”
BackgroundBlue-Light Receptors for Optogenetics
Losi, A., Gardner, K. H., & Möglich, A. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00163 · Cited by 255
Steinert, J., Schiml, S., Fauser, F., & Puchta, H. (2015) · The Plant Journal · doi:10.1111/tpj.13078 · Cited by 255
“This commonly used tool is derived from the type II CRISPR/Cas system and is based on the RNA-guided nuclease Cas9 from Streptococcus pyogenes (SpCas9) (for review see Doudna and Charpentier, 2014).”
MethodEstablishing RNA virus resistance in plants by harnessing CRISPR immune system
Zhang, T., Zheng, Q., Yi, X., An, H., Zhao, Y., Ma, S., & Zhou, G. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12881 · Cited by 252
“Conversely, the CRISPR/Cas9 is an adaptive molecular immunity system used by prokaryotes (Garneau et al., 2010; Horvath and Barrangou, 2010; Marraffini and Sontheimer, 2010), so eukaryotic viruses have not evolved in the presence of Cas9, meaning they are unlikely to have Cas9 evasion strategies.”
BackgroundDe Ravin, S. S., Li, L., Wu, X., Choi, U., Allen, C., Koontz, S., Lee, J., Theobald-Whiting, N., Chu, J., Garofalo, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah3480 · Cited by 258
Advances in therapeutic CRISPR/Cas9 genome editing
Savić, N., & Schwank, G. (2016) · Translational Research · doi:10.1016/j.trsl.2015.09.008 · Cited by 257
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges
Mout, R., Ray, M., Lee, Y.-W., Scaletti, F., & Rotello, V. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00057 · Cited by 243
“10 (1) Non-Homologous End Joining (NHEJ): this mechanism allows the cell to randomly insert or delete nucleotides at the CRISPR-mediated double-stranded DNA break site, resulting in gene coding sequence disruption.”
BackgroundRewritable multi-event analog recording in bacterial and mammalian cells
Tang, W., & Liu, D. R. (2018) · Science · doi:10.1126/science.aap8992 · Cited by 260
Streptococcus thermophilus CRISPR-cas9 systems enable specific editing of the human genome
Müller, M., Lee, C. M., Gasiunas, G., Davis, T. H., Cradick, T. J., Siksnys, V., Bao, G., Cathomen, T., & Mussolino, C. (2016) · Molecular Therapy · doi:10.1038/mt.2015.218 · Cited by 254
CRISPR/Cas9-mediated gene targeting in Arabidopsis using sequential transformation
Miki, D., Zhang, W., Zeng, W., Feng, Z., & Zhu, J.-K. (2018) · Nature Communications · doi:10.1038/s41467-018-04416-0 · Cited by 243
Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective
Zhang, D., Hussain, A., Manghwar, H., Xie, K., Xie, S., Zhao, S., Larkin, R. M., Qing, P., Jin, S., & Ding, F. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13383 · Cited by 233
“However, the applications of these technologies are limited because of the transfection inefficiency, design complexity and limitations on multiplexed mutations (Doudna and Charpentier, 2014).”
BackgroundMonfort, A., Di Minin, G., Postlmayr, A., Freimann, R., Arieti, F., Thore, S., & Wutz, A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.067 · Cited by 246
Torkamani, A., Andersen, K. G., Steinhubl, S. R., & Topol, E. J. (2017) · Cell · doi:10.1016/j.cell.2017.08.007 · Cited by 241
Pyramiding for Resistance Durability: Theory and Practice
Mundt, C. C. (2018) · Phytopathology® · doi:10.1094/phyto-12-17-0426-rvw · Cited by 235
Chehelgerdi, M., Chehelgerdi, M., Khorramian-Ghahfarokhi, M., Shafieizadeh, M., Mahmoudi, E., Eskandari, F., Rashidi, M., Arshi, A., & Mokhtari-Farsani, A. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01925-5 · Cited by 251
Sequence Programmable Peptoid Polymers for Diverse Materials Applications
Knight, A. S., Zhou, E. Y., Francis, M. B., & Zuckermann, R. N. (2015) · Advanced Materials · doi:10.1002/adma.201500275 · Cited by 245
The no-SCAR (Scarless Cas9 Assisted Recombineering) system for genome editing in Escherichia coli
Reisch, C. R., & Prather, K. L. J. (2015) · Scientific Reports · doi:10.1038/srep15096 · Cited by 251
Lesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
A multiplex CRISPR/Cas9 platform for fast and efficient editing of multiple genes in Arabidopsis
Zhang, Z., Mao, Y., Ha, S., Liu, W., Botella, J. R., & Zhu, J.-K. (2016) · Plant Cell Reports · doi:10.1007/s00299-015-1900-z · Cited by 245
“& Jian-Kang Zhu jkzhu@purdue.edu Streptococcus pyogenes derived CRISPR/Cas9 system as a powerful tool for genome editing can facilitate gene functional studies in a variety of organisms, including plants (Doudna and Charpentier 2014).”
CRISPR-GPT for agentic automation of gene-editing experiments
Qu, Y., Huang, K., Yin, M., Zhan, K., Liu, D., Yin, D., Cousins, H. C., Johnson, W. A., Wang, X., Shah, M., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01463-z · Cited by 140
“While recent advancements, such as OpenAI’s o1 preview, have improved reasoning abilities in areas such as mathematics and coding, progress in biological tasks remains comparatively limited.”
Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans
Paix, A., Folkmann, A., & Seydoux, G. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.023 · Cited by 256
Efficient CRISPR/Cas9 Genome Editing of Phytoene desaturase in Cassava
Odipio, J., Alicai, T., Ingelbrecht, I., Nusinow, D. A., Bart, R., & Taylor, N. J. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01780 · Cited by 234
“This versatility, plus high efficacy, and low cost have made CRISPR/Cas9 the most widely adopted of the three genome-editing technologies (Doudna and Charpentier, 2014).”
BackgroundCDK9-dependent RNA polymerase II pausing controls transcription initiation
Gressel, S., Schwalb, B., Decker, T. M., Qin, W., Leonhardt, H., Eick, D., & Cramer, P. (2017) · eLife · doi:10.7554/elife.29736 · Cited by 239
“Mutation of F103 at the CDK9 gene loci in Raji B cells was performed using the CRISPR-Cas9 system (Doudna and Charpentier, 2014; Hsu et al., 2014) as described (Mulholland et al., 2015) with minor modifications.”
MethodNon-viral gene therapy: Gains and challenges of non-invasive administration methods
Foldvari, M., Chen, D. W., Nafissi, N., Calderon, D., Narsineni, L., & Rafiee, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.012 · Cited by 238
A machine learning approach to predict metabolic pathway dynamics from time-series multiomics data
Costello, Z., & Martin, H. G. (2018) · npj Systems Biology and Applications · doi:10.1038/s41540-018-0054-3 · Cited by 242
“12 In general, we can make the DNA changes we intend (in model systems), but the end result on cell behavior is usually unpredictable.”
BackgroundBioethical issues in genome editing by CRISPR-Cas9 technology
AYANOĞLU, F. B., ELÇİN, A. E., & ELÇİN, Y. M. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1912-52 · Cited by 210
Mustafa, M. I., & Makhawi, A. M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00745-20 · Cited by 232
“Using genetic engineering, CRISPR-Cas systems have been adapted for use in humans and are now being modified and enhanced at an extraordinary pace, enabling precise editing of virtually any DNA or RNA molecule.[9-13]”
BackgroundRetractedGuideScan software for improved single and paired CRISPR guide RNA design
Perez, A. R., Pritykin, Y., Vidigal, J. A., Chhangawala, S., Zamparo, L., Leslie, C. S., & Ventura, A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3804 · Cited by 254
Katayama, T., Tanaka, Y., Okabe, T., Nakamura, H., Fujii, W., Kitamoto, K., & Maruyama, J.-I. (2016) · Biotechnology Letters · doi:10.1007/s10529-015-2015-x · Cited by 240
Additive Manufacturing of Precision Biomaterials
Guzzi, E. A., & Tibbitt, M. W. (2020) · Advanced Materials · doi:10.1002/adma.201901994 · Cited by 234
The New State of the Art: Cas9 for Gene Activation and Repression
La Russa, M. F., & Qi, L. S. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00512-15 · Cited by 229
Application of CRISPR-Cas9 genome editing technology in various fields: A review
Ansori, A. N., Antonius, Y., Susilo, R. J., Hayaza, S., Kharisma, V. D., Parikesit, A. A., Zainul, R., Jakhmola, V., Saklani, T., Rebezov, M., et al. (2023) · Narra J · doi:10.52225/narra.v3i2.184 · Cited by 208
“Advances in specificity, versatility, and applications continue to propel the field forward, opening up new possibilities for scientific research, therapeutic interventions, and agricultural advancements [13].”
BackgroundMethodInfluentialPartial DNA-guided Cas9 enables genome editing with reduced off-target activity
Yin, H., Song, C.-Q., Suresh, S., Kwan, S.-Y., Wu, Q., Walsh, S., Ding, J., Bogorad, R. L., Zhu, L. J., Wolfe, S. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2559 · Cited by 240
Engineering tolerance to industrially relevant stress factors in yeast cell factories
Deparis, Q., Claes, A., Foulquié-Moreno, M. R., & Thevelein, J. M. (2017) · FEMS Yeast Research · doi:10.1093/femsyr/fox036 · Cited by 230
“…precise genetic targeting and modification technology, that is based on clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas), has gained widespread application in many species because of its high efficacy and flexibility (Doudna and Charpentier 2014).”
BackgroundEnhancer redundancy in development and disease
Kvon, E. Z., Waymack, R., Gad, M., & Wunderlich, Z. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00311-x · Cited by 238
Exosome-mediated delivery of gene vectors for gene therapy
Duan, L., Xu, L., Xu, X., Qin, Z., Zhou, X., Xiao, Y., Liang, Y., & Xia, J. (2021) · Nanoscale · doi:10.1039/d0nr07622h · Cited by 238
Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
Papapetrou, E. P., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.38 · Cited by 238
Dramatic Enhancement of Genome Editing by CRISPR/Cas9 Through Improved Guide RNA Design
Farboud, B., & Meyer, B. J. (2015) · Genetics · doi:10.1534/genetics.115.175166 · Cited by 246
“…C. elegans THE use of site-specific nucleases with programmable tar-get specificity has transformed the art of genome editing and thereby revolutionized the dissection and manipulation of genome function (reviewed in Mali et al. 2013; Carroll 2014; Doudna and Charpentier 2014; Hsu et al. 2014).”
BackgroundCRISPR technology is revolutionizing the improvement of tomato and other fruit crops
Wang, T., Zhang, H., & Zhu, H. (2019) · Horticulture Research · doi:10.1038/s41438-019-0159-x · Cited by 225
DNA storage: research landscape and future prospects
Dong, Y., Sun, F., Ping, Z., Ouyang, Q., & Qian, L. (2020) · National Science Review · doi:10.1093/nsr/nwaa007 · Cited by 225
“Precise DNA writers, including site-specific recombinases [72], reverse transcriptases [77] and base editors [78], generate predetermined mutations, whereas pseudorandom DNA writers, including site-specific nucleases [79–81] and the Cas1–Cas2 complex [79], generate targeted but stochastic mutations.”
BackgroundCRISPR base editors: genome editing without double-stranded breaks
Eid, A., Alshareef, S., & Mahfouz, M. M. (2018) · Biochemical Journal · doi:10.1042/bcj20170793 · Cited by 224
Learning protein fitness models from evolutionary and assay-labeled data
Hsu, C., Nisonoff, H., Fannjiang, C., & Listgarten, J. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01146-5 · Cited by 204
“Minimizing the l2-regularized loss arising from the linear regression model in equation (1) is equivalent to minimizing the following objective function,”
BackgroundMethodInfluentialMethods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes
Hess, G. T., Tycko, J., Yao, D., & Bassik, M. C. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.029 · Cited by 234
“The ability to precisely edit genomic DNA using the CRISPR-Cas9 system has revolutionized the field of genome engineering (reviewed in Doudna and Charpentier, 2014; Hsu et al., 2014; Komor et al., 2017a; Sander and Joung, 2014; Shalem et al., 2015; Sternberg and Doudna, 2015; Wang et al., 2016).”
Nucleosome breathing and remodeling constrain CRISPR-Cas9 function
Isaac, R. S., Jiang, F., Doudna, J. A., Lim, W. A., Narlikar, G. J., & Almeida, R. (2016) · eLife · doi:10.7554/elife.13450 · Cited by 234
“Despite its successful adoption across numerous eukaryotic organisms, relatively few details are known of the mechanism by which bacterial CRISPR-Cas9 systems operate in eukaryotic cells (Doudna and Charpentier, 2014; Ghorbal et al., 2014; Vyas et al., 2015).”
InfluentialSelf-citationCardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology
Carrier, L., Mearini, G., Stathopoulou, K., & Cuello, F. (2015) · Gene · doi:10.1016/j.gene.2015.09.008 · Cited by 230
“Several targeting approaches have been developed in the past decade (Hammond and Wood, 2011; Doudna and Charpentier, 2014).”
BackgroundPrecision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks
Paix, A., Folkmann, A., Goldman, D. H., Kulaga, H., Grzelak, M. J., Rasoloson, D., Paidemarry, S., Green, R., Reed, R. R., & Seydoux, G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711979114 · Cited by 235
“Generation of targeted DSBs has been greatly accelerated in recent years by the discovery of CRISPR-Cas9, a programmable DNA endonuclease that can be targeted to a specific DNA sequence by a small “guide” RNA (crRNA) (2).”
Yang, L., Machin, F., Wang, S., Saplaoura, E., & Kragler, F. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01585-8 · Cited by 220
Genomic and Epigenomic Alterations in Cancer
Chakravarthi, B. V. S. K., Nepal, S., & Varambally, S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.02.023 · Cited by 223
Sugano, S. S., Nishihama, R., Shirakawa, M., Takagi, J., Matsuda, Y., Ishida, S., Shimada, T., Hara-Nishimura, I., Osakabe, K., & Kohchi, T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0205117 · Cited by 237
Jeong, M., Lee, Y., Park, J., Jung, H., & Lee, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114990 · Cited by 220
Genetically engineered crops help support conservation biological control
Romeis, J., Naranjo, S. E., Meissle, M., & Shelton, A. M. (2019) · Biological Control · doi:10.1016/j.biocontrol.2018.10.001 · Cited by 231
“Of those, CRISPR-Cas9 (Doudna and Charpentier, 2014) has gained the highest importance.”
BackgroundGenome editing in Ustilago maydis using the CRISPR–Cas system
Schuster, M., Schweizer, G., Reissmann, S., & Kahmann, R. (2016) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.09.001 · Cited by 225
Use of designer nucleases for targeted gene and genome editing in plants
Weeks, D. P., Spalding, M. H., & Yang, B. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12448 · Cited by 227
“Likewise, several excellent reviews regarding the use of gene editing tools in the broad scope of biology and medicine are available (Carroll, 2014; Doudna, 2015; Doudna and Charpentier, 2014; Hsu et al. , 2014).”
CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
Mayorga-Ramos, A., Zúñiga-Miranda, J., Carrera-Pacheco, S. E., Barba-Ostria, C., & Guamán, L. P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00649 · Cited by 207
A New Class of Medicines through DNA Editing
Porteus, M. H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1800729 · Cited by 229
Rapid characterization of CRISPR-Cas9 protospacer adjacent motif sequence elements
Karvelis, T., Gasiunas, G., Young, J., Bigelyte, G., Silanskas, A., Cigan, M., & Siksnys, V. (2015) · Genome Biology · doi:10.1186/s13059-015-0818-7 · Cited by 225
“Easy programmability of the Cas9 endonuclease using customizable RNAs, should, in theory, enable targeting of any sequence in the genome, however available sequence range is limited by the need of a short nucleotide sequence, termed a protospacer adjacent motif (PAM), that is absolutely required to initiate crRNA-medi…”
BackgroundMinimal PAM specificity of a highly similar SpCas9 ortholog
Chatterjee, P., Jakimo, N., & Jacobson, J. M. (2018) · Science Advances · doi:10.1126/sciadv.aau0766 · Cited by 228
Cell-Type-Specific CRISPR/Cas9 Delivery by Biomimetic Metal Organic Frameworks
Alyami, M. Z., Alsaiari, S. K., Li, Y., Qutub, S. S., Aleisa, F. A., Sougrat, R., Merzaban, J. S., & Khashab, N. M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11638 · Cited by 227
Regulatory Enhancer–Core-Promoter Communication via Transcription Factors and Cofactors
Zabidi, M. A., & Stark, A. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.10.003 · Cited by 228
Imaging and manipulating proteins in live cells through covalent labeling
Xue, L., Karpenko, I. A., Hiblot, J., & Johnsson, K. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1959 · Cited by 232
Current and emerging trends in techniques for plant pathogen detection
Venbrux, M., Crauwels, S., & Rediers, H. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1120968 · Cited by 204
“It is generally acknowledged that CRISPR-Cas-based molecular tools have revolutionized molecular biology, and in particular facilitated site-directed mutagenesis in a wide range of different organisms (Doudna and Charpentier, 2014).”
BackgroundPotential of Genome Editing to Improve Aquaculture Breeding and Production
Gratacap, R. L., Wargelius, A., Edvardsen, R. B., & Houston, R. D. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.06.006 · Cited by 221
“whole chromosomal region insertion) [72,75].”
Genomics of adaptation to host-plants in herbivorous insects
Simon, J.-C., d'Alencon, E., Guy, E., Jacquin-Joly, E., Jaquiery, J., Nouhaud, P., Peccoud, J., Sugio, A., & Streiff, R. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv015 · Cited by 215
“repeats (CrispR)/Cas9 endonuclease technology [131], will undoubtedly lead to efficient gene manipulation in these insect families.”
BackgroundFunctional Genetic Variants Revealed by Massively Parallel Precise Genome Editing
Sharon, E., Chen, S.-A. A., Khosla, N. M., Smith, J. D., Pritchard, J. K., & Fraser, H. B. (2018) · Cell · doi:10.1016/j.cell.2018.08.057 · Cited by 225
“However, this process is typically low-throughput, and often has variable efficiency of successful edits (Doudna and Charpentier, 2014; Hsu et al., 2014; Liu et al., 2017).”
BackgroundIn vivo base editing of post-mitotic sensory cells
Yeh, W.-H., Chiang, H., Rees, H. A., Edge, A. S. B., & Liu, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-04580-3 · Cited by 225
CRISPR/Cas9 advances engineering of microbial cell factories
Jakočiūnas, T., Jensen, M. K., & Keasling, J. D. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2015.12.003 · Cited by 219
Omole, A. E., & Fakoya, A. O. J. (2018) · PeerJ · doi:10.7717/peerj.4370 · Cited by 204
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.